Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa

FEMS Microbiology Letters

Volumn 279, Issue 1, 2008, Pages 36-39

  Ikonomidis, Alexandros ^a   Tsakris, Athanassios ^b   Kantzanou, Maria ^a   Spanakis, Nicholas ^b   Maniatis, Antonios N ^a   Pournaras, Spyros ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Carbapenem; Efflux pump overexpression; Heteroresistance; Mutants; OprD; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; BACTERIAL PROTEIN; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PROTEIN MEXB; PROTEIN MEXY; PROTEIN OPRD; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM ISOLATE; BACTERIUM MUTANT; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TRANSPORT KINETICS; UPREGULATION;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PORINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RNA, BACTERIAL; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

PSEUDOMONAS AERUGINOSA;

EID: 37349079943     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2007.00997.x     Document Type: Article

References (16)

1. CLSI (2007) Performance Standards for Antimicrobial Susceptibility Testing, 17th Informational Supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Dumas JL, van Delden C, Perron K Kohler T (2006) Analysis of antibiotic resistance genes in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol Lett 254 : 217 225.
3. Fernandez-Cuenca F, Pascual A, Martinez-Martinez L, Conejo MC Perea EJ (2003) Evaluation of SDS-polyacrylamide gel systems for the study of outer membrane protein profiles of clinical strains of Acinetobacter baumannii. J Basic Microbiol 43 : 194 201.
4. Kohler T, Epp SF, Curty LK Pechere JC (1999a) Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 181 : 6300 6305.
5. Kohler T, Michea-Hamzehpour M, Epp SF Pechere JC (1999b) Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother 43 : 424 427.
6. Lee A, Mao W, Warren MS, Mistry A, Hoshino K, Okumura R, Ishida H Lomovskaya O (2000) Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 182 : 3142 3150.
7. Livermore DM Woodford N (2006) The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 14 : 413 420.
8. Macia MD, Blanquer D, Togores B, Sauleda J, Perz JL Oliver A (2005) Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 49 : 3382 3386.
9. P1b integron over-expresses two efflux pumps and lacks OprD. J Antimicrob Chemother 60 : 132 135.
10. Ochs MM, McCusker MP, Bains M Hancock RE (1999) Negative regulation of the Pseudomonas aeruginosa outer membrane porin Oprd selective for imipenem and basic amino acids. Antimicrob Agents Chemother 43 : 1085 1090.
11. Poole K (2004) Efflux-mediated multiresistance in gram-negative bacteria. Clin Microbiol Infect 10 : 12 26.
12. VIM endemicity. J Antimicrob Chemother 56 : 761 764.
13. Pournaras S, Ikonomidis A, Markogiannakis A, Spanakis N, Maniatis AN Tsakris A (2007) Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J Med Microbiol 56 : 66 70.
14. Quale J, Bratu S, Gupta J Landman D (2006) Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50 : 1633 1641.
15. Sobel ML, McKay GA Poole K (2003) Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 47 : 3202 3207.
16. Tam VH, Schilling AN, Neshat S, Poole K, Melnick DA Coyle EA (2005) Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa. Antimicrob Agents Chemother 49 : 4920 4927.